These Analysts Revise Their Forecasts On Repligen Following Q2 Results

Core Viewpoint - Repligen Corporation reported second-quarter earnings that were in line with expectations, with solid revenue performance and positive outlook for future growth [1][2]. Financial Performance - Second-quarter sales reached $154.1 million, closely matching the consensus estimate of $154.12 million [1]. - Adjusted EPS for the quarter was 33 cents, consistent with consensus but down from $0.53 reported in the same quarter last year [1]. - First-half revenue totaled $305 million, achieving the year-to-date sales target [2]. Future Outlook - Repligen anticipates 2024 revenues between $620 million and $635 million, slightly lower than the previous guidance of $620 million to $650 million, but still in line with the consensus estimate of $636.6 million [2]. Market Reaction - Following the earnings announcement, Repligen shares increased by 5.3%, trading at $169.16 [3]. - Analysts adjusted their price targets post-earnings, with JP Morgan raising its target from $190 to $200 while maintaining an Overweight rating, and UBS lowering its target from $205 to $185 while keeping a Buy rating [3].